Hims & Hers Health Inc. reported third-quarter 2026 results on November 9, 2026, after the market closed. Following the announcement, shares fell 7.3% in mid-day trading and traded as low as $23.91 during the session.
The company reported a quarterly loss of $0.37 per share, compared with a consensus estimate of a $0.05 loss. The wider-than-expected loss appears to have driven the negative market reaction.
Revenue was $753.21 million, above the $698.90 million consensus estimate. Revenue increased 38.2% year over year.